Three Things in Fundz Data: October 29, 2026

Here is what stood out in Fundz verified events from October 22 to October 28, 2026, each compared with the prior week and the 4-week average. Each item has one company we checked at its own filing, plus what you can do with it this week.

1. 32 executive seats opened in public filings this week, up from 14

For recruiters

From October 22 to October 28, 2026, public companies reported 32 executive departures in their filings where no permanent successor was named, up from 14 the prior week and a 4-week average of 23.75. Of the 32, 18 named no successor at all, 10 named an interim and 4 said a search is underway.

NetScout Systems filed on October 26, 2026 that Chief Operating Officer Sanjay Munshi resigned from all positions on October 22, 2026, effective immediately. The filing names no successor.

Why it matters: A COO who leaves effective immediately with no successor named is an open search the company has not publicly assigned to anyone. This week, get two or three operators you could put in front of the CEO and make the call.

Company filing, October 26, 2026 · See it in Fundz

2. 10 CFO seats opened in public filings this week, double the prior week

For fractional executives

Of this week's 32 open executive seats, 10 were CFO roles, up from 5 the prior week and a 4-week average of 5.75. That is the most open CFO seats in any of the last five weeks.

Seres Therapeutics filed on October 26, 2026 that Executive Vice President and Chief Financial Officer Marella Thorell resigned on October 22, 2026, effective November 15, 2026, and is expected to advise the company through the transition. The filing names no successor.

Why it matters: A company with a CFO leaving on November 15 and no successor named needs finance coverage while it searches. That gap is the work a fractional CFO does, so reach out before the departure date.

Company filing, October 26, 2026 · See it in Fundz

3. 73 raises of $1M to $7.5M showed up in funding filings this week

For capital advisors

From October 22 to October 28, 2026, Fundz logged 73 funding filings of $1M to $7.5M, against 81 the prior week and a 4-week average of 71. Many raises this size are never announced, so the filing is often the only public record.

Navispend, Inc. filed on October 23, 2026 that it had sold $5,312,226 of a $16,312,226 equity offering to 4 investors, with the first sale on October 9, 2026. We found no company press release or news story about it.

Why it matters: With $11M of the offering still unsold, the company is likely still raising and may not have an advisor for the rest of the round. Reach out this week with a specific view on how to close it.

Funding filing, October 23, 2026 · See it in Fundz

Want this for your own market?

Fundz scores every verified event against your market and shows who to call and who you already know there. No credit card to see it.

See plansBook a demo

Frequently asked

What counts as an open executive seat?

An open seat is an executive departure that a public company reports in its own filing where no permanent replacement is named. From October 22 to October 28, 2026, Fundz found 32 of them, up from 14 the prior week. 18 named no successor, 10 named an interim and 4 announced a search. The roles included 10 CFOs, 5 CEOs and 4 COOs, which gives recruiters a dated list of searches.

Why do CFO departures matter to fractional executives?

When a CFO leaves and no permanent successor is named, someone still has to close the books, run the audit and talk to investors. This week, 10 of the 32 open seats were CFO roles, up from 5 the prior week and a 4-week average of 5.75. Seres Therapeutics, for example, has a CFO leaving on November 15, 2026 and no successor named in its filing.

How can a raise have no press release?

Companies raising private capital file a short notice of the sale, and many never announce it. From October 22 to October 28, 2026, Fundz logged 73 such filings between $1M and $7.5M, against 81 the prior week and a 4-week average of 71. Navispend, Inc., for example, reported $5,312,226 sold of a $16,312,226 offering on October 23, 2026, and we found no press release or news story about it.

Published every Thursday from verified events in Fundz. Every number was checked against its primary source before publishing.

Share this post: